NSC5844

CAS No. 140926-75-6

NSC5844 ( NSC5844; NSC-5844; NSC 5844; RE640 )

Catalog No. M17281 CAS No. 140926-75-6

NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 Get Quote
10MG 80 Get Quote
25MG 132 Get Quote
50MG 196 Get Quote
100MG 291 Get Quote
200MG 435 Get Quote
500MG 698 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NSC5844
  • Note
    Research use only, not for human use.
  • Brief Description
    NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.
  • Description
    NSC5844, also known as RE640, is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic properties.
  • Synonyms
    NSC5844; NSC-5844; NSC 5844; RE640
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    CCR1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    140926-75-6
  • Formula Weight
    383.27
  • Molecular Formula
    C20H16Cl2N4
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    c1cc2c(ccnc2cc1Cl)NCCNc1c2ccc(cc2ncc1)Cl
  • Chemical Name
    N,N'-bis(7-chloroquinolin-4-yl)ethane-1,2-diamine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhang H, et al. Biomed PharmacOthers. 2008 Feb;62(2):65-9.
molnova catalog
related products
  • Copanlisib dihydroch...

    Copanlisib dihydrochloride is an ATP-competitive pan-class I PI3K inhibitor (IC50s: 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI3Kδ, PI3Kβ and PI3Kγ).

  • hSMG-1 inhibitor 11j

    hSMG-1 inhibitor 11j is a pyrimidine derivative. hSMG-1 inhibitor 11j is a potent and selective inhibitor of hSMG-1, IC50 = 0.11 nM.

  • LTURM34

    LTURM34 is an inhibitor of DNA-PK with IC50 of 34 nM. LTURM34 displays effective antiproliferative activity in a wide range of tumor cell lines.